• Female Hormone Health Check  - The National Blood Test Clinic
  • Female Hormone Health Check  - The National Blood Test Clinic
1 4

My Store

Advanced Prostate Profile

Advanced Prostate Profile

Concerned about prostate function or interested in proactive prostate screening? This advanced screening panel offers a deeper assessment of your prostate status, going beyond traditional PSA tests. Developed by our research and development team, the Prostate Profile incorporates innovative biomarkers to support risk stratification for prostate cancer and inflammation, aiding in early intervention and better care decisions.

£152.00 GBP
£152.00 GBP
Sale Sold out
Taxes included.
View full details

  • Total Prostate Specific Antigen 

  • Free Prostate Specific Antigen 

  • Interleukin-8 

  • Monocyte Chemotactic Protein-1 

  • Epidermal Growth Factor 

  • Prostate Cancer Risk Score

Why Choose a Prostate Profile?

Prostate concerns, including cancer, are increasingly common in men over 50, but early detection significantly improves outcomes. This profile combines established markers like TPSA and FPSA with inflammatory and growth-related proteins, offering a more accurate way to distinguish between low- and high-risk individuals. It can help reduce unnecessary biopsies and support smarter treatment decisions in both primary and specialist care.

Why Choose Clinic-Based Blood Testing?

  • Accurate Results

    Samples are collected by trained professionals for precise, lab-quality outcomes.

  • Fast Health Insights

    Quick, In-clinic testing enables early detection and faster follow-up care.

  • Expert Oversight

    Healthcare staff guide the process and help interpret your results.

  • Nationwide Access

    Convenient locations across the UK through The National Phlebotomy Clinic.

FAQs

What does a prostate profile blood test check for?

The Prostate Profile measures both traditional PSA markers and additional inflammatory and growth-related proteins to evaluate prostate cancer risk more comprehensively.

How is this different from a standard PSA test?

Unlike standard PSA testing, this profile includes novel biomarkers such as Interleukin-8 and MCP-1, which enhance the ability to differentiate between benign conditions and higher-risk scenarios.

Who should consider this test?

Men over 50, or those with a family history of prostate cancer or urinary symptoms, should consider this test for proactive prostate health management.

Does a high PSA always mean cancer?

Not necessarily. PSA levels can rise due to benign enlargement, inflammation, or infection. This profile helps refine the interpretation by including more targeted biomarkers.

What is the Prostate Cancer Risk Score?

This score is generated by combining all included markers to provide a personalised estimate of prostate cancer risk, supporting informed clinical decisions.